NBTK.DE vs. P500.DE

Last updated Jun 5, 2026

NBTK.DE (Invesco Nasdaq Biotech UCITS ETF) and P500.DE (Invesco S&P 500 UCITS ETF) are both exchange-traded funds - NBTK.DE is a Health & Biotech Equities fund tracking the Nasdaq Biotechnology, while P500.DE is a S&P 500 fund tracking the S&P 500 Index. Both are passively managed. Over the past 5 years, NBTK.DE returned 5.63%/yr vs 14.99%/yr for P500.DE. A 0.58 correlation means they provide meaningful diversification when combined. NBTK.DE charges 0.40%/yr vs 0.05%/yr for P500.DE.

Performance

NBTK.DE vs. P500.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and Invesco S&P 500 UCITS ETF (P500.DE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NBTK.DE achieves a 4.27% return, which is significantly lower than P500.DE's 11.47% return.

NBTK.DE

• 1D: 2.92%
• 1M: 0.38%
• YTD: 4.27%
• 6M: 3.76%
• 1Y: 39.20%
• 3Y*: 9.94%
• 5Y*: 5.63%
• 10Y*: —

P500.DE

• 1D: -0.10%
• 1M: 4.39%
• YTD: 11.47%
• 6M: 10.93%
• 1Y: 25.73%
• 3Y*: 19.07%
• 5Y*: 14.99%
• 10Y*: 15.16%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NBTK.DE vs. P500.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
NBTK.DE Invesco Nasdaq Biotech UCITS ETF	4.27%	18.60%	4.57%	2.51%	-6.11%	7.46%	14.59%	17.24%
P500.DE Invesco S&P 500 UCITS ETF	11.47%	4.88%	32.56%	22.69%	-14.05%	41.05%	7.04%	7.83%

Correlation

The correlation between NBTK.DE and P500.DE is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.45
Correlation (3Y) Calculated over the trailing 3-year period	0.49
Correlation (5Y) Calculated over the trailing 5-year period	0.53
Correlation (All Time) Calculated using the full available price history since Oct 22, 2019	0.58

The correlation between NBTK.DE and P500.DE shifts across timeframes, from 0.45 (1 year) to 0.58 (all time), reflecting how their relationship changes across market environments.

Return for Risk

NBTK.DE vs. P500.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NBTK.DE

NBTK.DE Risk / Return Rank: 71
NBTK.DE Sharpe Ratio Rank: 61
NBTK.DE Sortino Ratio Rank: 63
NBTK.DE Omega Ratio Rank: 56
NBTK.DE Calmar Ratio Rank: 92
NBTK.DE Martin Ratio Rank: 84

P500.DE

P500.DE Risk / Return Rank: 70
P500.DE Sharpe Ratio Rank: 69
P500.DE Sortino Ratio Rank: 67
P500.DE Omega Ratio Rank: 71
P500.DE Calmar Ratio Rank: 73
P500.DE Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NBTK.DE vs. P500.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and Invesco S&P 500 UCITS ETF (P500.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NBTK.DE	P500.DE	Difference
Sharpe ratio: Return per unit of total volatility	2.03	2.23	-0.21
Sortino ratio: Return per unit of downside risk	2.87	3.03	-0.17
Omega ratio: Gain probability vs. loss probability	1.34	1.41	-0.08
Calmar ratio: Return relative to maximum drawdown	6.16	3.62	+2.55
Martin ratio: Return relative to average drawdown	17.06	12.91	+4.15
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NBTK.DE vs. P500.DE - Sharpe Ratio Comparison

The current NBTK.DE Sharpe Ratio is 2.03, which is comparable to the P500.DE Sharpe Ratio of 2.23. The chart below compares the historical Sharpe Ratios of NBTK.DE and P500.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NBTK.DE	P500.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.03	2.23	-0.21
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.27	0.98	-0.70
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.94	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.42	1.01	-0.59

Drawdowns

NBTK.DE vs. P500.DE - Drawdown Comparison

The maximum NBTK.DE drawdown since its inception was -30.99%, smaller than the maximum P500.DE drawdown of -33.78%. Use the drawdown chart below to compare losses from any high point for NBTK.DE and P500.DE.

Drawdown Indicators

	NBTK.DE	P500.DE	Difference
Max Drawdown Largest peak-to-trough decline	-30.99%	-33.78%	+2.79%
Max Drawdown (1Y) Largest decline over 1 year	-6.24%	-7.11%	+0.87%
Max Drawdown (3Y) Largest decline over 3 years	-29.35%	-23.34%	-6.01%
Max Drawdown (5Y) Largest decline over 5 years	-30.99%	-23.34%	-7.65%
Max Drawdown (10Y) Largest decline over 10 years	—	-33.78%	—
Current Drawdown Current decline from peak	-1.44%	-0.40%	-1.04%
Average Drawdown Average peak-to-trough decline	-10.62%	-3.85%	-6.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.26%	1.99%	+0.27%

Volatility

NBTK.DE vs. P500.DE - Volatility Comparison

Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) has a higher volatility of 6.41% compared to Invesco S&P 500 UCITS ETF (P500.DE) at 2.65%. This indicates that NBTK.DE's price experiences larger fluctuations and is considered to be riskier than P500.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NBTK.DE	P500.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.41%	2.65%	+3.76%
Volatility (6M) Calculated over the trailing 6-month period	14.11%	7.59%	+6.52%
Volatility (1Y) Calculated over the trailing 1-year period	19.00%	11.52%	+7.48%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.30%	15.17%	+5.13%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	22.05%	16.07%	+5.98%

NBTK.DE vs. P500.DE - Expense Ratio Comparison

NBTK.DE has a 0.40% expense ratio, which is higher than P500.DE's 0.05% expense ratio.

Dividends

NBTK.DE vs. P500.DE - Dividend Comparison

Neither NBTK.DE nor P500.DE has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both NBTK.DE and P500.DE in my portfolio?

NBTK.DE and P500.DE have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, NBTK.DE or P500.DE?

On fees, P500.DE is cheaper at 0.05% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, NBTK.DE or P500.DE?

P500.DE is cheaper with a 0.05% expense ratio, compared with 0.40% for NBTK.DE.

What is the main difference between NBTK.DE and P500.DE?

NBTK.DE is categorized as Health & Biotech Equities, while P500.DE is S&P 500. NBTK.DE tracks Nasdaq Biotechnology, while P500.DE tracks S&P 500 Index. Their fees differ too: 0.40% for NBTK.DE and 0.05% for P500.DE.